Behind a table laden with a mix of food platters, chips bags, drinks, and slow cookers, a large map of the U.S. presided over a gathering for the NCI Frederick postbaccalaureate and postdoctoral fellows finishing their assignments.  The map, speckled with colored spots that indicated where fellows were heading next, was a focal point of the afternoon. The celebration was the second annual Fellows Sendoff Potluck...

We invite you to participate in this quarter’s Trivia Challenge. Winners of this quarterly challenge will earn bragging rights, and the first person to respond to all questions correctly will receive a virtual shoutout with the next batch of questions.

NCI Frederick researchers and colleagues are improving therapies that modify and equip a patient’s own immune cells to target their solid tumors. Their modification, while still at an early stage of development, can potentially minimize the risk that the armed cells will be therapeutically rejected.

The Frederick Postbac Committee, comprising NCI Frederick postbaccalaureate fellows, held their second annual Frederick Postbac Poster Day in March. The event, organized by the Committee and collaborating staff, showcased postbac research over the past year and gave postbacs an opportunity to practice sharing their science with an audience of their peers. All NCI employees were invited to attend, and the Frederick Postbac Committee was pleased with the turnout, which included postbacs, postdocs, and senior scientists alike.

Academic researchers, along with scientists at NCI Frederick, are repurposing a harmless bacterial virus to reactivate dormant HIV-infected T cells—a type of white blood cell—for destruction. Their proof-of-concept study, published in iScience, is an early step in testing this platform.